Last updated on August 16th, 2026 at 09:58 pm

Last updated on August 16th, 2026 at 09:58 pm

The HILL Model: Concussion Treatment
with Low-Dose Lithium

Discover the latest in concussion prevention and recovery strategies. Learn about the HILL Model for managing neuroinflammation with microdoses of Lithium.

HILL Model: Low-Dose Lithium Breakthrough for Concussion Treatment

The HILL Model and the Biology of Concussion

image promoting the HILL model for treating concussions

Low-Dose Lithium Breakthrough for Concussion Treatment and TBI

The HILL model (Head impact–inflammation–low-dose lithium) links head-impact mechanics and neuroinflammation to the neuroprotective properties of low-dose lithium. Recent data suggest that low-dose lithium safely dampens trauma-induced cytokine spikes (such as IL-6, IL-1β, and TNF-α) to improve recovery outcomes after traumatic brain injury (TBI). By targeting the biochemical cascade triggered by concussion, this approach works to preserve brain health, prevent cellular damage, and accelerate recovery. The HILL model offers a roadmap for moving from reactive symptom monitoring to proactive, mechanism-based brain protection. It isn’t just about treating a “hit”—it’s about managing the biological cascade that follows. Curious about how this could change the future of sports medicine, military readiness, and long-term brain health? Read Dr. Sudhir Gadh’s full peer-reviewed publication on Cell Trends Open.

Stop Waiting and Start Recovering: How the HILL Model Targets the Biology of Concussion Neuroinflammation with Low-Dose Lithium

For years, the standard approach to concussion treatment has been simple: stop, rest, and wait. While rest is a necessary first step, this “wait-and-see” mindset overlooks the hidden reality of traumatic brain injury (TBI): neuroinflammation. For athletes, military personnel, and others exposed to repeated head impact, failing to address this inflammatory cascade leaves the brain vulnerable to increased cerebral edema and secondary lesions, threatening long-term cognitive decline. While the skull provides rigid external protection, neural tissue has not evolved to withstand the rapid acceleration and deceleration imposed by modern contact sports, military training, and combat operations. Even impacts below the threshold of a diagnosed concussion can disrupt neuronal membranes and stretch axons.

Rethinking Brain Injury, Prevention, and Recovery: The HILL Model for Recovery

Traditional treatment protocols are shifting from a wait-and-see approach to managing head trauma as a static mechanical event toward a more dynamic, observable, and actionable sequence of biological processes measured by inflammatory biomarkers, offering strong potential for more comprehensive, versatile, and impactful diagnostic and treatment options. The HILL model enables this shift in perspective, framing head impacts not merely as mechanical events but as observable and modifiable biological processes. When a head impact occurs, it sets off a “domino effect” inside the brain. The dynamic nature of the HILL model framework supports a proactive approach to concussion management, shifting the focus to biological processes rather than only mechanical impacts.

Beyond Symptoms: Neuroinflammation and the Biology of Concussion

Understanding the HILL model framework helps in grasping the complexities of concussion and the crucial role of low-dose lithium in mitigating neuroinflammation. Concussion and repeated head-impact exposure are major challenges in sports medicine, military readiness, and public health. Millions of athletes, both youth and adult, from American football players to professional fighters, are exposed each year to biomechanical forces the human brain did not evolve to withstand [1]. Certain positions in American football can sustain hundreds or thousands of subconcussive impacts per season [2]. These impacts, though clinically silent, initiate measurable neuroinflammatory cascades that may accumulate over time [3]. The burden of disease is enormous: chronic traumatic encephalopathy (CTE), persistent post-concussive syndrome, cognitive decline, neurodegenerative disease, chronic pain, sleep disturbance, emotional lability, functional impairment, and elevated risk of depression and suicide 1, 2. In this opinion article, we address whether neuroinflammatory responses to head impact can be quantitatively linked to mechanical exposure and safely modulated using low-dose lithium (LL). The HILL model framework is essential for understanding these neuroinflammatory cascades and their implications for overall brain health.

How Low-Dose Lithium Protects the Brain

With the HILL model framework in mind, we can better understand low-dose lithium’s protective benefits and improve recovery strategies. It explains how mechanical head impacts trigger a delayed biological cascade of neuroinflammation, and how microdoses of lithium can disrupt this cascade to promote brain recovery.

graph showing how low-dose Lithium protects the brain

Low-Dose Lithium Carbonate (20-112 mg) Serves as a Potential Neuroprotective Agent by:

How Low-Dose Lithium Promotes Sructural & Functional Recovery

Lithium carbonate supports long-term neurological resilience through multiple molecular and cellular mechanisms that protect, rebuild, and stabilize brain tissue. Beyond immediate protection, lithium carbonate supports long-term neurological resilience by:

By addressing the underlying damage from TBI, low-dose lithium may help improve:

Lithium Inflammation Psychiatry (LIP) Study at the Karolinska Institute

Rigorous scientific research on concussion biomarkers and the cascade of neuroinflammation is imperative for developing novel approaches to head-impact treatment and recovery. Dr. Sudhir Gadh and researchers at the Karolinska Institute are seeking funding to expand initial findings and formalize the HILL model as a systematic, actionable framework. The model integrates head-impact mechanics, the inflammatory response, and the neuroprotective, regenerative effects of low-dose lithium to mitigate brain injury, reduce neuronal damage, and improve short- and long-term cognitive and motor outcomes while facilitating functional recovery and improving overall quality of life. By reframing concussion as a modifiable biological process rather than a static mechanical event, the HILL model framework offers a proactive, precision-based pathway for better recovery and long-term brain health.

What are Safe Doses of Lithium for Brain Health?

Many of lithium’s potentially beneficial effects occur at doses below traditional psychiatric ranges. Microdose or nutritional lithium, approximately 0.3–2 mg/day elemental, has shown measurable effects in reducing inflammatory markers, enhancing neuronal resilience, slowing cognitive decline in early Alzheimer’s studies, and reducing suicidality and violence in population studies of naturally occurring lithium exposure. The safety profile at these low doses appears favorable. Serum monitoring is generally not required at nutritional levels, and renal and thyroid risks are far lower than with conventional psychiatric dosing. At these low doses, lithium acts more like a nutrient modulator than a high-dose pharmaceutical.

Future Directions for Brain Health

The HILL model argues that the long-term consequences of head impacts do not have to be inevitable. By integrating wearable sensors to track impact forces, measuring blood-based inflammatory biomarkers, and using low-dose lithium, sports medicine and public health systems can shift from simply managing concussion symptoms to actively building brain resilience.

About the Lead Researcher: Dr. Sudhir Gadh

Dr. Sudhir Gadh is a New York City-based psychiatrist and an affiliate researcher at the Karolinska Institute in Sweden and the Galicia Sur Health Research Institute in Spain. With a background as a commander in the U.S. Navy Medical Corps Reserve, his clinical and research work focuses on neuroinflammation, biomarker-driven psychiatry, and the role of low-dose lithium in mental health, neurodegeneration, and performance medicine. He is the principal investigator of the Karolinska Lithium-Inflammation Psychiatry (LIP) Study and a pioneer in integrating clinical practice with systems-level approaches to improve long-term brain resilience.

Conclusion

The future of concussion management is shifting from symptom-based reaction to mechanism-based intervention. The HILL model represents a bold, testable roadmap for protecting the brains of athletes, military personnel, and aging adults alike. To move past the era of invisible injuries, we must embrace a biology-driven approach. This shift toward the HILL model framework emphasizes the importance of addressing underlying biological mechanisms alongside traditional treatment methods.

Read the Full Story

By embracing the HILL model framework, we can better advocate for science-backed concussion protocols that prioritize athlete safety and recovery. To explore the foundational data and the full scientific argument for this paradigm shift, read the complete publication in the Read the complete peer-reviewed Trends Open journal article here: HILL model: Head impact, inflammation, low-dose lithium. Are you ready to prioritize long-term brain resilience? Bookmark this research, share it with your coaching staff or medical providers, and join the conversation on demanding better, science-backed concussion protocols.

LIP Research Study News & Media

image linking to the Lithium Inflammation Psychiatry Research Study

Read the Lithium Inflammation Psychiatry (LIP) Research Study at Karolinska Institute (PDF)

Learn about the LIP research study on Low-Dose Lithium for mental health.

image linking to blog post on the health effects of low-dose Lithium

Health Effects of Low-Dose Lithium: A Systematic Review

Empirical Data from Interventional Studies on Low-Dose Lithium's Effect on Psychiatric and Neurological Health

image promoting the LIP Hill Model research team at Karolinska Institute

Meet the Lithium Inflammation Psychiatry Research Team from the Karolinska Institute (KI)

Join us in advancing the Lithium Inflammation Psychiatry (LIP) study.